<DOC>
	<DOCNO>NCT00404651</DOCNO>
	<brief_summary>The purpose trial clinically confirm manufacture process final bulk product investigational DTaP-IPV-HB-PRP~T vaccine consistent . The primary objective demonstrate equivalence three batch DTaP-IPV-HB-PRP~T vaccine , term seroprotection seroconversion rate vaccine antigens three-dose primary series . The secondary objective : - To describe group , immunogenicity parameter antigens one month third dose primary series - To assess overall safety group one month third dose primary series .</brief_summary>
	<brief_title>Lot Consistency Study DTaP-IPV-HB-PRP~T Vaccine Administered 2-4-6 Months Age Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Two month old infant day inclusion Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg Informed consent form sign one parent guardian two independent witness Able attend schedule visit comply trial procedure Received Bacillus Calmette Guerin ( BCG ) vaccine birth one month life agreement national immunization calendar . Exclusion Criteria : Participation another clinical trial four week precede ( first ) trial vaccination Planned participation another clinical trial present trial period Congenital acquire immunodeficiency Systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance Chronic illness stage could interfere trial conduct completion Blood bloodderived product receive since birth Any vaccination four week precede first trial visit Any plan vaccination ( except BCG , rotavirus , pneumococcal conjugate vaccine ) study Documented history pertussis , tetanus , diphtheria , poliomyelitis , Haemophilus influenzae type b hepatitis B infection ( ) ( confirm either clinically , serologically microbiologically ) Previous vaccination hepatitis B , pertussis , tetanus , diphtheria , poliovirus , Haemophilus influenzae type b infection ( ) Known personal maternal history HIV , Hepatitis B ( HBsAg ) Hepatitis C seropositivity Thrombocytopenia bleed disorder contraindicate intramuscular vaccination History seizure Febrile ( rectal equivalent temperature ≥ 38.0°C ) acute illness day inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Hepatitis B</keyword>
	<keyword>Poliomyelitis</keyword>
	<keyword>Invasive Haemophilus influenzae type b .</keyword>
</DOC>